| Title |
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
|
|---|---|
| Published in |
New England Journal of Medicine, August 2020
|
| DOI | 10.1056/nejmoa1916623 |
| Pubmed ID | |
| Authors |
Nadia Howlader, Gonçalo Forjaz, Meghan J Mooradian, Rafael Meza, Chung Yin Kong, Kathleen A Cronin, Angela B Mariotto, Douglas R Lowy, Eric J Feuer |
X Demographics
The data shown below were collected from the profiles of 325 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 100 | 31% |
| Spain | 36 | 11% |
| United Kingdom | 11 | 3% |
| France | 10 | 3% |
| Canada | 9 | 3% |
| Mexico | 9 | 3% |
| Brazil | 7 | 2% |
| India | 6 | 2% |
| Italy | 4 | 1% |
| Other | 36 | 11% |
| Unknown | 97 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 188 | 58% |
| Scientists | 74 | 23% |
| Practitioners (doctors, other healthcare professionals) | 58 | 18% |
| Science communicators (journalists, bloggers, editors) | 5 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 701 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 701 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 80 | 11% |
| Student > Ph. D. Student | 59 | 8% |
| Other | 55 | 8% |
| Student > Bachelor | 55 | 8% |
| Student > Master | 46 | 7% |
| Other | 113 | 16% |
| Unknown | 293 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 176 | 25% |
| Biochemistry, Genetics and Molecular Biology | 66 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 29 | 4% |
| Nursing and Health Professions | 16 | 2% |
| Agricultural and Biological Sciences | 16 | 2% |
| Other | 79 | 11% |
| Unknown | 319 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1300. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#10,358
of 25,726,194 outputs
Outputs from New England Journal of Medicine
#492
of 32,656 outputs
Outputs of similar age
#515
of 426,659 outputs
Outputs of similar age from New England Journal of Medicine
#22
of 318 outputs
Altmetric has tracked 25,726,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,656 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,659 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 318 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.